# Comparing Effects of Liraglutide and Bariatric Surgery on Weight Loss, Liver Function, Body Composition, Insulin Resistance, Endothelial Function and Biomarkers of Non-alcoholic Steatohepatitis (NASH) in Obese Asian Adults

> **NCT02654665** · PHASE3 · UNKNOWN · sponsor: **Changi General Hospital** · enrollment: 36 (estimated)

## Conditions studied

- Non-alcoholic Fatty Liver Disease (NAFLD)
- Weight Loss
- Non-alcoholic Steatohepatitis (NASH)

## Interventions

- **BEHAVIORAL:** Lifestyle modification
- **DRUG:** Liraglutide

## Key facts

- **NCT ID:** NCT02654665
- **Lead sponsor:** Changi General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-03
- **Primary completion:** 2017-12
- **Final completion:** 2018-12
- **Target enrollment:** 36 (ESTIMATED)
- **Last updated:** 2018-01-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02654665

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02654665, "Comparing Effects of Liraglutide and Bariatric Surgery on Weight Loss, Liver Function, Body Composition, Insulin Resistance, Endothelial Function and Biomarkers of Non-alcoholic Steatohepatitis (NASH) in Obese Asian Adults". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT02654665. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*